129 related articles for article (PubMed ID: 38091020)
21. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
22. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma.
Lewis JT; Hartmann LC; Vierkant RA; Maloney SD; Shane Pankratz V; Allers TM; Frost MH; Visscher DW
Am J Surg Pathol; 2006 Jun; 30(6):665-72. PubMed ID: 16723843
[TBL] [Abstract][Full Text] [Related]
23. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and histopathology of benign breast diseases and breast cancer in southern Thailand.
Kotepui M; Piwkham D; Chupeerach C; Songsri A; Charoenkijkajorn L
Eur J Gynaecol Oncol; 2014; 35(6):670-5. PubMed ID: 25556273
[TBL] [Abstract][Full Text] [Related]
25. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
[TBL] [Abstract][Full Text] [Related]
26. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.
Aroner SA; Collins LC; Schnitt SJ; Connolly JL; Colditz GA; Tamimi RM
Breast Cancer Res; 2010; 12(4):R61. PubMed ID: 20691043
[TBL] [Abstract][Full Text] [Related]
27. Assessment of Machine Learning of Breast Pathology Structures for Automated Differentiation of Breast Cancer and High-Risk Proliferative Lesions.
Mercan E; Mehta S; Bartlett J; Shapiro LG; Weaver DL; Elmore JG
JAMA Netw Open; 2019 Aug; 2(8):e198777. PubMed ID: 31397859
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.
Neal L; Sandhu NP; Hieken TJ; Glazebrook KN; Mac Bride MB; Dilaveri CA; Wahner-Roedler DL; Ghosh K; Visscher DW
Mayo Clin Proc; 2014 Apr; 89(4):536-47. PubMed ID: 24684875
[TBL] [Abstract][Full Text] [Related]
29. Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy.
Sherman ME; Vierkant RA; Kaggal S; Hoskin TL; Frost MH; Denison L; Visscher DW; Carter JM; Winham SJ; Jensen MR; Radisky DC; Vachon CM; Degnim AC
Cancer Prev Res (Phila); 2020 Nov; 13(11):967-976. PubMed ID: 32718942
[TBL] [Abstract][Full Text] [Related]
30. Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
Degnim AC; Visscher DW; Berman HK; Frost MH; Sellers TA; Vierkant RA; Maloney SD; Pankratz VS; de Groen PC; Lingle WL; Ghosh K; Penheiter L; Tlsty T; Melton LJ; Reynolds CA; Hartmann LC
J Clin Oncol; 2007 Jul; 25(19):2671-7. PubMed ID: 17563394
[TBL] [Abstract][Full Text] [Related]
31. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
[TBL] [Abstract][Full Text] [Related]
32. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
Arthur R; Wang Y; Ye K; Glass AG; Ginsberg M; Loudig O; Rohan T
Breast Cancer Res Treat; 2017 Oct; 165(3):623-631. PubMed ID: 28643020
[TBL] [Abstract][Full Text] [Related]
33. Benign breast disease as a breast cancer risk in Japanese women.
Nomura Y; Tashiro H; Katsuda Y
Jpn J Cancer Res; 1993 Sep; 84(9):938-44. PubMed ID: 8407559
[TBL] [Abstract][Full Text] [Related]
34. Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up.
Krieger N; Hiatt RA
Am J Epidemiol; 1992 Mar; 135(6):619-31. PubMed ID: 1580238
[TBL] [Abstract][Full Text] [Related]
35. The significance of atypical lobular hyperplasia at percutaneous breast biopsy.
Dmytrasz K; Tartter PI; Mizrachy H; Chinitz L; Rosenbaum Smith S; Estabrook A
Breast J; 2003; 9(1):10-2. PubMed ID: 12558664
[TBL] [Abstract][Full Text] [Related]
36. Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort.
Zeinomar N; Phillips KA; Daly MB; Milne RL; Dite GS; MacInnis RJ; Liao Y; Kehm RD; Knight JA; Southey MC; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; John EM; Hopper JL; Terry MB
Int J Cancer; 2019 Jul; 145(2):370-379. PubMed ID: 30725480
[TBL] [Abstract][Full Text] [Related]
37. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study.
Nassar A; Visscher DW; Degnim AC; Frank RD; Vierkant RA; Frost M; Radisky DC; Vachon CM; Kraft RA; Hartmann LC; Ghosh K
Breast Cancer Res Treat; 2015 Sep; 153(2):397-405. PubMed ID: 26264469
[TBL] [Abstract][Full Text] [Related]
38. Family history of breast cancer, age and benign breast disease.
Webb PM; Byrne C; Schnitt SJ; Connolly JL; Jacobs T; Peiro G; Willett W; Colditz GA
Int J Cancer; 2002 Jul; 100(3):375-8. PubMed ID: 12115556
[TBL] [Abstract][Full Text] [Related]
39. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
[TBL] [Abstract][Full Text] [Related]
40. A cohort study of oral contraceptive use and risk of benign breast disease.
Rohan TE; Miller AB
Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
